ABBV vs BRKR

The Advanced Deterministic Scorecard reveals a mixed health profile with a Piotroski F-Score of 4/9 indicating stable but not strong fundamentals, while the absence of an Altman Z-Score prevents a clear distress risk assessment. Despite robust operating margins and consistent revenue growth, the company faces significant headwinds from negative earnings growth, an extremely high P/E ratio, and a dangerously elevated payout ratio. Strong historical price performance and analyst buy sentiment are counterbalanced by bearish insider activity and deteriorating profitability trends. The stock appears to trade at a substantial premium to its intrinsic value, suggesting limited margin of safety.

The Advanced Deterministic Scorecard reveals a weak fundamental profile with a Piotroski F-Score of just 2/9, indicating poor financial health. Despite a reasonable Price/Book of 3.13 and a Forward P/E of 23.49 that is below sector average, the company is unprofitable with a negative profit margin (-0.61%) and ROE (-1.09%). Revenue is flat, earnings volatility is high, and insider selling of $2.76M over the past six months signals management skepticism. While the technical rebound from 6-month lows has lifted price performance (+20.3% over 6M), the long-term trend remains weak with a 3Y return of -28.5%, and analyst target of $54.07 appears optimistic given deteriorating fundamentals.